SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Increase Decrease In Operating Lease Liability
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Increase Decrease In Operating Lease Liability of -$2.05 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$1.14K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$904.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$904.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$905.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.46K, a 959.79% decline from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2024 was $286.00, a 98.21% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2023 was $16.00K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2022 was -$5.69K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-24 | -$2.05K 10-Q · filed 2026-09-24 | -$2.95K derived: sum of 3 quarters · filed 2026-09-24 | -$3.86K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2026-03-31 | -$904.00 10-Q · filed 2026-05-15 | -$1.81K derived: sum of 2 quarters · filed 2026-05-15 | -$2.71K derived: sum of 3 quarters · filed 2026-05-15 | -$3.15K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2025-12-31 | -$904.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.81K derived: sum of 2 quarters · filed 2026-03-31 | -$2.25K derived: sum of 3 quarters · filed 2026-09-24 | -$2.46K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$905.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.35K derived: sum of 2 quarters · filed 2026-09-24 | -$1.55K 10-Q · filed 2025-11-13 | -$1.77K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2025-06-30 | -$441.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-24 | -$650.00 10-Q · filed 2026-09-24 | -$862.00 derived: sum of 3 quarters · filed 2026-09-24 | -$1.07K derived: sum of 4 quarters · filed 2026-09-24 | ||
| 2025-03-31 | -$209.00 10-Q · filed 2026-05-15 | -$421.00 derived: sum of 2 quarters · filed 2026-05-15 | -$626.00 derived: sum of 3 quarters · filed 2026-05-15 | -$389.00 derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$212.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$417.00 derived: sum of 2 quarters · filed 2026-03-31 | -$180.00 derived: sum of 3 quarters · filed 2026-03-31 | $286.00 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$205.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $32.00 derived: sum of 2 quarters · filed 2025-11-13 | $498.00 10-Q · filed 2025-11-13 | $7.14K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $237.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $703.00 10-Q · filed 2025-08-13 | $7.35K derived: sum of 3 quarters · filed 2025-08-13 | $16.73K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $466.00 10-Q · filed 2025-05-08 | $7.11K derived: sum of 2 quarters · filed 2025-05-08 | $16.50K derived: sum of 3 quarters · filed 2025-05-08 | $18.36K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $6.64K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $16.03K derived: sum of 2 quarters · filed 2025-02-26 | $17.89K derived: sum of 3 quarters · filed 2025-02-26 | $16.00K 10-K · filed 2025-02-26 | ||
| 2023-09-30 | $9.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $11.25K derived: sum of 2 quarters · filed 2024-11-13 | $9.36K 10-Q · filed 2024-11-13 | $7.65K derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $1.86K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-09-04 | -$30.00 10-Q · filed 2024-09-04 | -$1.74K derived: sum of 3 quarters · filed 2024-09-04 | -$3.07K derived: sum of 4 quarters · filed 2024-09-04 | ||
| 2023-03-31 | -$1.89K 10-Q/A · filed 2024-09-04 | -$3.60K derived: sum of 2 quarters · filed 2024-09-04 | -$4.93K derived: sum of 3 quarters · filed 2024-09-04 | -$6.26K derived: sum of 4 quarters · filed 2024-09-04 | ||
| 2022-12-31 | -$1.71K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-04 | -$3.04K derived: sum of 2 quarters · filed 2024-09-04 | -$4.36K derived: sum of 3 quarters · filed 2024-09-04 | -$5.69K 10-K/A · filed 2024-09-04 | -$66.55K 10-K · filed 2023-03-15 | |
| 2022-09-30 | -$1.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.66K derived: sum of 2 quarters · filed 2023-11-13 | -$3.99K 10-Q · filed 2023-11-13 | -$49.00K 10-Q · filed 2022-11-14 | -$19.52K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$1.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$2.66K 10-Q · filed 2023-08-14 | -$18.20K derived: sum of 3 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$1.33K 10-Q · filed 2023-05-25 | -$16.87K derived: sum of 2 quarters · filed 2023-05-25 | ||||
| 2021-12-31 | -$15.54K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$58.47K 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$42.93K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |